Skip to main content
. 2018 Aug 29;16(5):6003–6012. doi: 10.3892/ol.2018.9371

Table I.

Clinical information of the 57 patients with liver and biliary cancer.

Characteristics Category Number
Sex M 50
F 7
Age at diagnosis, mean years ± SD 52.1±10.6
BMI index <18.5 2
18.5–23.9 24
>23.9 31
Smoking Yes 21
Occasionally 3
No 31
N/A 2
Alcohol Yes 15
Occasionally 5
No 35
N/A 2
HBV Yes 42
No 15
Alcoholic hepatitis Yes 5
No 52
Fatty liver Yes 3
No 53
N/A 1
Cirrhosis and liver fibrosis Yes 41
No 15
N/A 1
Family cancer history Yes 27
No 30
Hepatectomy surgery Yes 51
No 3
N/A 3
ECOG score 0 52
1 4
N/A 1
Metastases Yes 6
No 50
N/A 1
Degree of differentiation Undifferentiated 0
Low 5
Middle 49
High 0
N/A 3
Largest diameter of the <2 4
tumor, cm 2–5 22
5–10 18
≥10 9
NA 4
Albumin, g/l <35 6
35–50 49
>50 1
N/A 1
Bilirubin, mg/l 1–10 20
>10 36
N/A 1
Platelet <100 9
100–300 43
>300 4
N/A 1
AFP (ng/ml) <25 34
25–500 11
>500 11
N/A 1
ALT 0–40 36
>40 19
N/A 2
Child-Pugh classification 0/A 52
B/C/D 1
N/A 4
BCLC 0/A 12
B 23
C 16
N/A 6
Stage I 2
II 28
III 17
IV 7
N/A 3
Lesion Primary 52
Secondary 2
N/A 3
Nodules Single 42
Multiple 14
N/A 1
Number of tumors 1 42
>1 7
N/A 8
Microvascular invasion (tumor thrombus) Yes 44
No 9
N/A 4
Large vascular invasion (tumor thrombus) Yes 4
No 49
N/A 4
Portal vein invasion (tumor thrombus) Yes 9
No 44
N/A 4
Peripheral nerve invasion Yes 4
No 49
N/A 4

SD, standard deviation; BMI, body mass index; HBV, hepatitis B virus; AFP, α-fetoprotein; ALT, alanine aminotransferase; BCLC, Barcelona Clinic Liver Cancer; NA, not available.